SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-22-018962
Filing Date
2022-07-08
Accepted
2022-07-08 18:25:35
Documents
1
Period of Report
2022-07-07

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 6580
  Complete submission text file 0001493152-22-018962.txt   8069
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Issuer) CIK: 0000876343 (see all company filings)

IRS No.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O LINEAGE CELL THERAPEUTICS, INC. 2173 SALK AVENUE, SUITE 200 CARLSBAD CA 92008
Business Address
Hernandez Alexandra (Reporting) CIK: 0001841756 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-12830 | Film No.: 221075553